RAPT Therapeutics Inc (RAPT) — Defensive Interval Ratio

Latest as of September 2025: 3259 days

RAPT Therapeutics Inc (RAPT) has a Defensive Interval Ratio of 3259 days as of September 2025. Defensive assets of $119.41 Million (cash $-, short-term investments $119.41 Million, receivables $-) cover 3259 days of daily cash needs of $36.64K/day. Check RAPT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

3259 days
Days of operational coverage

Defensive Assets

$119.41 Million
Cash + ST Investments + Receivables

Daily Cash Need

$36.64K
Current Liabilities ÷ 365

Current Liabilities

$13.38 Million
USD

RAPT Therapeutics Inc Defensive Interval Ratio (2020–2024)

This chart shows how RAPT Therapeutics Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 3259 days, meaning defensive assets of $119.41 Million can fund 3259 days of operations without new revenue. Also explore net asset momentum of RAPT Therapeutics Inc to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for RAPT Therapeutics Inc (2020–2024)

The table below presents the year-by-year Defensive Interval Ratio for RAPT Therapeutics Inc from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is RAPT Therapeutics Inc worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 463 days $61.32 Million $132.47K/day $- $61.32 Million ▼ -1399 days
2023 1862 days $111.38 Million $59.82K/day $- $111.38 Million ▼ -3530 days
2022 5392 days $210.12 Million $38.97K/day $- $210.12 Million ▼ -909 days
2021 6301 days $165.63 Million $26.29K/day $- $165.63 Million ▲ +3609 days
2020 2692 days $86.59 Million $32.17K/day $- $86.59 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)